Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Bilateral Salpingectomy for Ovarian Cancer Prevention

Am J Obstet Gynecol; ePub 2016 Oct 31; Hanley, et al

Hysterectomy with bilateral salpingectomy is significantly increasing in the US and is not associated with increased risks of postoperative complications, a recent study found. The Nationwide Inpatient Sample identified women aged ≥15 years without gynecologic cancer who underwent inpatient hysterectomy or tubal sterilization, with and without bilateral salpingectomy, between 2008 and 2013. Researchers found:

  • 425,180 women were included, representing a national cohort of 2,036,449 women.
  • There was an increase in the uptake of hysterectomy with bilateral salpingectomy of 371% across the study period.
  • There were only 1,195 salpingectomies for sterilization.
  • There was no increased risk for blood transfusion post-operative complications, post-operative infections, or fevers in the women who had hysterectomy with bilateral salpingectomy compared with those undergoing hysterectomy alone.

Citation:

Hanley GE, McAlpine JN, Pearce CL, Miller D. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States. [Published online ahead of print October 31, 2016]. Am J Obstet Gynecol. doi:10.1016/j.ajog.2016.10.035.